Common drug testing practices face criticism in ASAM document

Draft recommendations from the American Society of Addiction Medicine (ASAM) and the American College of Medical Toxicology (ACMT) warn against misuse of drug testing in substance use treatment programs and other clinical care settings. Among the practices the organizations criticize in the draft document are universal testing for the sole purpose of screening for substance use, observed urine testing of patients, and administratively discharging a patient from care based only on an unexpected test result.